The transparent gel filling the eye, the vitreous body, plays a critical role in ocular structure and retinal stability. However, with aging or trauma, it can undergo degenerative changes leading to vitreous disorders that significantly affect visual function. Conditions such as vitreomacular adhesion, posterior vitreous detachment, and hemorrhagic vitreous opacities are frequently encountered in clinical settings. Accurate differentiation of these disorders through high-resolution optical coherence tomography and ultrasonography allows clinicians to tailor treatment based on severity and anatomical findings. While conservative observation is often sufficient, persistent or vision-threatening cases may require surgical intervention such as pars plana vitrectomy. Researchers are now exploring pharmacologic agents to induce vitreolysis non-surgically, offering promising alternatives in selected cases. Ongoing studies are also focusing on the molecular mechanisms of vitreous degeneration, aiming to develop future therapies that address the condition at its root rather than only managing symptoms.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Diagnostic uncertainty with a patient presenting with raised intra-ocular pressure. A unique case of choroidal melanoma
Raheel Faiz, UHCW, United Kingdom
Title : Subthreshold micropulse laser for residual subretinal fluid after vitrectomy in myopic tractional maculopathy?A randomized controlled trial
Zhang Xifang, Beijing Tongren Hospital, China
Title : Hitting the trifecta-ocular syphilis
Lisa Sunny, Aravind Eye Hospital, India
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : The effect of low hypermetropia correction and office-based orthoptic training on binocular vision parameters in children with convergence insufficiency
Agnieszka Rosa, Orticus Center for the Treatment of Strabismus and vision Disorders, Poland